Slideshows Images Quizzes

Copyright © 2018 by RxList Inc. RxList does not provide medical advice, diagnosis or treatment. See additional information.

Provisc

Last reviewed on RxList: 8/15/2019
Drug Description

PROVISC®
(1% Sodium Hyaluronate) Viscoelastic Preparation

DESCRIPTION

PROVISC® (sodium hyaluronate) Viscoelastic Preparation is a sterile, non-pyrogenic, high molecular weight, noninflammatory highly purified fraction of sodium hyaluronate, dissolved in physiological sodium chloride phosphate buffer. Each mL of PROVISC contains active 10.0mg sodium hyaluronate; 0.56mg dibasic sodium phosphate, anhydrous; 0.04mg monobasic sodium phosphate; 8.4mg sodium chloride; hydrochloric acid and/or sodium hydroxide to adjust pH and water for injection.

Indications

INDICATIONS

PROVISC (sodium hyaluronate) Viscoelastic Preparation is indicated for use as an ophthalmic surgical aid in the anterior segment during cataract extraction and intraocular lens (IOL) implantation.

PROVISC (sodium hyaluronate) Viscoelastic Preparation serves to maintain a deep anterior chamber during anterior segment surgery allowing reduced trauma to the corneal endothelium and surrounding ocular tissues. The viscoelastic properties of PROVISC (sodium hyaluronate) Viscoelastic Preparation help to push back the vitreous face and prevent formation of a flat chamber postoperatively.

QUESTION

About how much does an adult human brain weigh? See Answer
Dosage

DOSAGE AND ADMINISTRATION

No information provided.

HOW SUPPLIED

PROVISC (sodium hyaluronate) is a sterile, non-pyrogenic, viscoelastic preparation(sodium hyaluronate, 10mg/mL, dissolved in physiological sodium chloride phosphate buffer) supplied in disposable glass syringes delivering 0.55mL or 0.85mL.

Each mL of PROVISC Viscoelastic Preparation contains 10mg sodium hyaluronate; 0.56mg dibasic sodium phosphate, anhydrous; 0.04mg monobasic sodium phosphate; 8.4mg sodium chloride; hydrochloric acid and/or sodium hydroxide to adjust pH and QS water for injection. PROVISC (sodium hyaluronate) syringes are aseptically packaged in blister packs and terminally sterilized.

STORAGE RECOMMENDATIONS

Store in refrigerator (2° †? 8°C, 36° †? 46°F). Protect from freezing. Protect from light.

Refrigerated PROVISC (sodium hyaluronate) Viscoelastic Preparation should be allowed to attain room temperature prior to use (approximately 20 †? 40 minutes depending on quantity).

Side Effects & Drug Interactions

SIDE EFFECTS

PROVISC (sodium hyaluronate) Viscoelastic Preparation is extremely well-tolerated after injection into human eyes during ophthalmic surgical procedures. As with most viscoelastic ophthalmic preparations, a transient rise in intraocular pressure has been reported in some cases.

Postoperative inflammatory reactions such as hypopyon and iritis have been reported with the use of ophthalmic viscoelastic preparations, as well as incidents of corneal edema and corneal decompensation. Their relationship to the use of sodium hyaluronate (PROVISC (sodium hyaluronate) ) has not been established.

DRUG INTERACTIONS

No information provided.

SLIDESHOW

Digestive Disorders: Common Misconceptions See Slideshow
Warnings & Precautions

WARNINGS

No information provided.

PRECAUTIONS

  • Precautions normally associated with anterior segment surgical procedures should be observed.

  • Postoperative increases in intraocular pressure have been reported with sodium hyaluronate products. The IOP should be carefully monitored and appropriate therapy instituted if significant increases occur.

  • It is recommended that PROVISC (sodium hyaluronate) material be removed by irrigation and/or aspiration at the close of surgery. Do not overfill the anterior chamber.

  • PROVISC (sodium hyaluronate) material is obtained from microbial fermentation by a purified proprietary process. Although precautions have been taken to make this device protein-free and it has been tested in animals for allergenic response, this device, used in susceptible persons, may produce allergenic responses.

  • This product contains dry natural rubber (latex).

  • In addition to the above, the following precautions should be observed:

    -Do not reuse cannulas.
    -Use only if material is clear.
    -Avoid trapping air bubble.

Overdosage & Contraindications

OVERDOSE

No information provided.

CONTRAINDICATIONS

At present there are no known contraindications to the use of PROVISC (sodium hyaluronate) Viscoelastic Preparation when used as recommended; care should be used in patients with hypersensitivity to any components in this material (see Precautions).

Clinical Pharmacology

CLINICAL PHARMACOLOGY

CHARACTERISTICS

Sodium hyaluronate is a high molecular weight polysaccharide, composed of sodium, glucuronate and N-acetyl-glucosamine which forms a repeating disaccharide unit by linking alternately beta 1-3 and beta 1-4 glycosidic bonds. The 1% viscous and transparent material, PROVISC, is a specific fraction of sodium hyaluronate, developed as an aid in ophthalmic surgery. It acts as a space occupying fluid that is replaced by the body†?s natural fluids.

Medication Guide

PATIENT INFORMATION

No information provided. Please refer to the WARNINGS and PRECAUTIONS sections.

FDA Logo

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Health Solutions From Our Sponsors

CONTINUE SCROLLING FOR RELATED SLIDESHOW